Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this biotech stock.

President Donald Trump and the CEO of Pfizer announce a new drug pricing deal to lower drug costs for Americans.

Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer. speaks in the Oval Office of the White House on Tuesday, with, from left, Secretary of Health and Human ...

WASHINGTON (AP) — Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar ...

Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer. speaks in the Oval Office of the White House on Tuesday, with, from left, Secretary of Health and Human ...

The announcement, which Trump made with Pfizer CEO Albert Bourla at the White House, came as the Republican president has for months sought to lower drug costs. It also came as Washington faced a ...

Pfizer agreed to lower drug costs under a deal with the Trump administration, pledging Medicaid pricing cuts and $70B U.S. investment.

By Alun John, Danilo Masoni, Dimitri Rhodes and Maggie Fick LONDON (Reuters) -European healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer ...

According to the deal, which the Trump administration signed on Tuesday, Pfizer agreed to sell its existing drugs to Medicaid patients at the lowest price offered in other developed nations and also ...

The administration also announced it will create a website, TrumpRx, that will help consumers buy drugs directly from manufacturers.